VC  KensaGroup

http://www.kensagroup.com





     Office Locations:

950 Danby Road, Suite 300
Ithaca, NY 14850
Phone: 607-330-2307
Fax: 607-330-2319

 

Stages:

  • Early


 

Industries:

  • Consumer Products & Services
  • Energy & Clean Tech
  • Financial Services
  • Food & Agriculture
  • Information Technology
  • Life Sciences & Healthcare
  • Manufacturing & Industrial
  • Medical Device

  •  

    Description:

    KensaGroup creates, launches and develops leading edge intellectual property platforms into successful technology-based businesses. KensaGroup uses a proprietary approach to identify and evaluate promising discoveries from universities and corporate research initiatives, then creates the necessary scientific, institutional, and financial bridges that lead from initial discovery to successful commercialization. KensaGroup focuses on technologies that address looming economic or regulatory issues. KensaGroup's business model centers on a network of university and corporate partners that leverages the capabilities of a team. KensaGroup was launched in 2000 and has evaluated over 3,000 technologies for commercialization opportunities. The scientific backbone of KensaGroup's portfolio is chemistry-centric. The breadth of the portfolio is such that it touches a diverse array of industries including biotech, chemicals, materials, energy, medical device, pharmaceutical, financial services, agriculture, electronics and automotive industries.


     

    Funds:


      Fund Name


      Amount


      Date

    Get funds under management for this firm including Fund name, Dollar size of fund raise, and Vintage with a National Database subscription or New York Database subscription.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or New York Database subscription.
    Bruce Ganem Ph.D. Director
    Eric D. Eisenhut Managing Director
    Eugene Yarussi Director
    Kirsten Johnston Barker Entrepreneur in Residence
    Peter Hessney Director of Consulting and Advisory Services

     

    Portfolio companies include:


      BeetNPath
        web link


      Fina Technologies
        web link


      Gene Network Sciences
        web link


      GNS Healthcare
        web link


      Grainful
        web link


      iFyber
        web link


      Kensa
        web link


      MedHesives
        web link


      North Sea Resins
        web link


      NovaSterilis
        web link


      Novomer
        web link


      Prendismo
        web link


     

    Recent News:


      There is no recent news for KensaGroup.